Stoma reversal after surgery for complicated acute diverticulitis: A multicentre retrospective study

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Roig, JV
  • Salvador, A
  • Espinosa, J
  • Rosello, V
  • Hernandis, J
  • Ruiz-Carmona, MD
  • Uribe, N
  • Garcia-Calvo, R
  • Bernal, JC
  • Garcia-Armengol, J
  • Soc Valenciana Cirugia

Grupos

Abstract

Introduction: The aim was to analyse the stoma reversal rate after surgery for complicated acute diverticulitis (CAD), and more specifically the end-stoma-reversal, as well as the delay, feasibility, complications and risk factors for stoma maintenance. Methods: A multicentre retrospective study of patients who had undergone urgent surgery for CAD with stoma formation in ten hospitals during a period of 6 years. The frequency of reversal over time and the factors affecting the decision for reversal were analysed. Results: Out of 385 patients operated for CAD, 312 underwent stoma creation: 292 end colostomies and 20 diverting stomas. During follow-up, stoma reversal surgery was performed in 161 patients (51.6%) after a median of 9 months. The main causes for not performing stoma reversal were comorbidities and the death of the patient. Advanced age was an adverse factor in the multivariate analysis, and the actuarial rate of reversal was higher in men and in patients with no previous Hartmann's operation. Stoma reversal surgery was completed in all but one patient, and a loop ileostomy was associated in four. Morbidity and mortality rates were 35.7% and 1.9%, respectively. A total of 8.4% of patients underwent re-operation, and 6% experienced an anastomotic leak. Twelve patients remained with a stoma after the attempted reconstruction surgery. Conclusions: Surgery for CAD is frequently associated with an end stoma, which will ultimately not be reversed in almost 50% of patients. Moreover, reversal surgery is frequently delayed and is associated with significant morbidity and mortality. (C) 2018 AEC. Published by Elsevier Espana, S.L.U. All rights reserved.

Datos de la publicación

ISSN/ISSNe:
0009-739X, 1578-147X

CIRUGIA ESPANOLA  ELSEVIER DOYMA SL

Tipo:
Article
Páginas:
283-291
Factor de Impacto:
0,189 SCImago
Cuartil:
Q3 SCImago

Citas Recibidas en Web of Science: 3

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Acute diverticulitis; Stoma reversal; Hartmann's reversal; Hartmann's operation; Postoperative complications

Campos de estudio

Proyectos asociados

WIBEC. WIRELESS IN-BODY ENVIRONMENT COMMUNICATIONS.

Investigador Principal: VICENTE PONS BELTRÁN

675353 . COMISION EUROPEA . 2016

MODELOS DE HÍGADO AISLADO PERFUNDIDO PARA EL RESCATE DE ÓRGANOS Y TRASLACIÓN DE LA TERAPIA GÉNICA EN EL TRASPLANTE: ESCENARIOS HUMANO "EX VIVO" Y PORCINO "IN VIVO"

Investigador Principal: RAFAEL LÓPEZ ANDÚJAR

2017_0270_CRC_LOPEZ . FUNDACION MUTUA MADRILEÑA . 2017

Ileostomía vistual combinada con endoscopia postoperatoria ebn cáncer de recto con escisión total mesorrectal. ¿podemos evitar estomas innecesarios? estudio prospectivo observacional multicénctrico.

Investigador Principal: BLAS FLOR LORENTE

PI17/00863 . INSTITUTO DE SALUD CARLOS III . 2018

"TIMing Evaluation of Stoma closure” Cierre precoz vs tardío del estoma derivativo tras cirugía de cáncer de recto.

Investigador Principal: MATTEO FRASSON

2018_0078_CRC_FRASSON . ASOCIACIÓN ESPAÑOLA DE COLOPROCTOLOGÍA (AECP) . 2018

Terápia génica no-viral con 1L 10 para el tratamiento de la enfermedad inflamatoria intestinal. Estudio preliminar con piezas de cólon humano ex vivo.

Investigador Principal: MATTEO FRASSON

PI18/01658 . INSTITUTO DE SALUD CARLOS III . 2019

INDIVIDUALIZED PERIOPERATIVE HEMODYNAMIC GOAL-DIRECTED THERAPY IN MAJOR ABDOMINAL SURGERY (IPEGASUS-TRIAL).

Investigador Principal: ÓSCAR DÍAZ CAMBRONERO

IPEGASUS . 2017

ESTUDIO ALEATORIZADO MULTICÉNTRICO EN FASE III DE RADIOTERAPIA DE CORTA DURACIÓN SEGUIDA DE QUIMIOTERAPIA PREOPERATORIA DE LARGA DURACIÓN Y CIRUGÍA EN EL CÁNCER RECTAL PRIMARIO DE ALTO RIESGO EN COMPARACIÓN CON QUIMIORRADIOTERAPIA CONVENCIONAL Y CIRUGÍA Y OPTIMA QUIMIOTERAPIA ADYUVANTE.

Investigador Principal: JORGE APARICIO URTASUN

RAPIDO

REGISTRO ESPAÑOL SOBRE FUGAS EN ANASTOMOSIS DE COLON.

Investigador Principal: MATTEO FRASSON

ANACO

ENSAYO CLÍNICO MULTICÉNTRICO ALEATORIZADO EN PACIENTES CON CÁNCER COLO-RECTAL CON METÁSTASIS IRRESECABLES. IMPACTO DE LA RESECCIÓN TUMORAL VS QUIMIOTERAPIA SOLA SOBRE LA SUPERVIVENCIA.

Investigador Principal: FRANCISCO JAVIER VAQUE URBANEJA

01CCRE-IV

UTILIDAD DE UNA MALLA SUPRAAPONEURÓTICA COMO PROFILAXIS DE LA EVENTRACIÓN DE LINEA MEDIA TRAS RESECCIÓN ONCOLOGICA COLORRECTAL. ESTUDIO PROSPECTIVO ALEATORIZADO MONOCÉNTRICO.

Investigador Principal: MATTEO FRASSON

PEACE . 2016

Cita

Compartir